Majority of women with early-stage breast cancer undergoing imaging despite guidelines
the ONA take:
According to a new study published in the Canadian Medical Association Journal, researchers have found that the majority of women with early-stage breast cancer undergo imaging for metastatic cancer despite guidelines from three organizations that recommend against imaging for metastatic cancer in asymptomatic women with early-stage breast cancer.
For the study, researchers identified 26,547 women with stage I or II breast cancer diagnosed between 2007 and 2012 in Ontario, Canada.
Of those, 86% underwent at least one imaging test to detect whether the patient had developed metastatic cancer.
Specifically, imaging was performed in 80% and 93% of patients with stage I and stage II breast cancer, respectively.
The American Society of Clinical Oncology, the National Comprehensive Cancer Network, and Cancer Care Ontario recommend against imaging for the detection of metastatic cancer in asymptomatic women with stage I or II breast cancer due to the very low likelihood of metastases.
There is also a high risk for false-positives that can result in further unnecessary tests, costs, and worry.
The majority of women with early-stage breast cancer undergo imaging for metastatic cancer despite guidelines.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|